COMPASS Pathways plc
Status: Publicly traded
Direct answer
COMPASS Pathways plc is publicly traded on NASDAQ under the ticker CMPS.
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase...
Can you invest in COMPASS Pathways plc?
Yes. COMPASS Pathways plc is publicly traded on NASDAQ under the ticker CMPS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for COMPASS Pathways plc
Detailed equity research is provided by MarketSnap.